Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PVCT - Provectus Biopharma partners to test rose bengal as anti-fungal and anti-oral bacterial agent

PVCT - Provectus Biopharma partners to test rose bengal as anti-fungal and anti-oral bacterial agent

Provectus Biopharmaceuticals Inc
  • Provectus ( OTC:PVCT ) said it had expanded its sponsored research program with Michio Kurosu, Professor at the University of Tennessee Health Science Center to investigate its pharmaceutical-grade rose bengal to treat anti-fungal and anti-oral bacterial infections.
  • The Kurosu team plans to evaluate the in vitro activity of Provectus’ rose bengal against different fungal strains and to conduct susceptibility tests against fungal and bacterial mouth microbes.

For further details see:

Provectus Biopharma partners to test rose bengal as anti-fungal and anti-oral bacterial agent
Stock Information
Company Name: Provectus Biopharmaceuticals Inc
Stock Symbol: PVCT
Market: OTC
Website: provectusbio.com
Menu
PVCT PVCT Quote PVCT Short PVCT News PVCT Articles PVCT Message Board
Get PVCT Alerts

News, Short Squeeze, Breakout and More Instantly...